Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Registry of Patients With Sleep Disordered Breathing Treated With DreamStation BiPAP autoSV.

NCT03421704 is registered in ClinicalTrials.gov with Philips Respironics as lead sponsor.

NCT NCT03421704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03421704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Registry of Patients With Sleep Disordered Breathing Treated With DreamStation BiPAP autoSV.
Lead sponsor
Philips Respironics
Phase
Observational
Overall status
Completed
Start date
January 25, 2018
Completion date
April 20, 2023
Enrollment
129 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

central sleep apnea, cheyne-stokes respiration, complex sleep apnea, mixed sleep apnea